Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

This Could Drain Your Retirement Savings Faster Than a Bear Marketfool.com
There's one dangerous factor that needs to be on your radar.
Via The Motley Fool · September 5, 2026
Anthropic Could Be the Next Mega IPO: 2 Magnificent Stocks That Already Own a Piece of the AI Unicornfool.com
These companies have already recorded billions in profits from their Anthropic stakes.
Via The Motley Fool · September 5, 2026
Warren Buffett's Successor Greg Abel Spent $4.5 Billion Buying 1 Stock Last Quarter, and He Spent At Least $3.3 Billion Buying More This Quarterfool.com
Abel is finally deploying Berkshire's growing capital.
Via The Motley Fool · September 5, 2026
The Nuclear Energy Boom: Where the Industry Really Stands Heading Into 4Q 2026fool.com
Massive demand for electricity has led to a nuclear renaissance, but it really hasn't hit the U.S. just yet.
Via The Motley Fool · September 5, 2026
Top Tanzania Safari Tours for 2026: Best Safari Packages, Wildlife Destinations, Game Drives, Itineraries, and Accommodation Optionstalkmarkets.com
Tanzania is one of Africa’s best destinations for wildlife, beautiful landscapes, cultural experiences, and outdoor adventures. From wide open grasslands f
Via Talk Markets · September 5, 2026
Fed Chair Kevin Warsh Just Shifted the Central Bank's Entire Focus on Inflation in One Sentencefool.com
Jerome Powell’s successor has flipped the script on inflation.
Via The Motley Fool · September 5, 2026
Kraken Robotics Stock Is Down 55% -- Is September the Month to Buy the Dip?fool.com
Kraken Robotics stock has fallen out of favor. Is this a buying opportunity?
Via The Motley Fool · September 5, 2026
Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signalmarketbeat.com
Zscaler's fiscal Q4 2026 results beat estimates with 24.9% revenue growth and wider margins, while analysts raised price targets despite lingering sales leadership transition concerns.
Via MarketBeat · September 5, 2026
Anthropic Weighs Lockup Periods Longer Than the Standard 180 Days. Here's Why That Matters.fool.com
This approach has the potential to change how tech companies handle insider share lockups as part of an IPO.
Via The Motley Fool · September 5, 2026
Rocket Lab's Revenue Is Soaring. So Why Is the Stock Sinking?fool.com
The rocket flight company might push back the timeline yet again for the debut of its new rocket type.
Via The Motley Fool · September 5, 2026
Ameren SVP Finance Ryan Martin Sells 971 Shares for $107,000fool.com
Martin retains 27,432 total shares, showing continued alignment with the success of the company.
Via The Motley Fool · September 5, 2026
Why I'm Still Investing in VTI Right Now No Matter What the Stock Market Doesfool.com
When the stock market gets choppy, I take comfort from the lessons of history.
Via The Motley Fool · September 5, 2026
If a Downturn Is Coming, 50 Years of Market History Says This Is the Single Best Responsefool.com
Wall Street history is pretty clear: if there's a bear market on the way, you'll probably want to follow Winnie the Pooh's sage advice.
Via The Motley Fool · September 5, 2026
This Week in Tesla: Elon Musk Touts 'Golden Era' With Cybercab Amid Fleet Expansionbenzinga.com
Tesla's Austin Cybercab launch stole the headlines as Elon Musk touts rare-earth-free motor, Starlink onboard.
Via Benzinga · September 5, 2026
Is Duolingo the Next Netflix-Style Comeback Story?marketbeat.com
Evercore upgraded Duolingo to Outperform with a $210 price target, arguing AI chatbot fears were overblown as user growth, retention, and engagement remain strong.
Via MarketBeat · September 5, 2026
Here's How Many Shares of Procter & Gamble You'd Need for $15,000 in Yearly Dividendsfool.com
Although this consumer staples stock has underperformed the market, it should be a top choice for income investors.
Via The Motley Fool · September 5, 2026
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?fool.com
Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.
Via The Motley Fool · September 5, 2026
XRP Price Prediction as Ripple USD (RLUSD) Hits $2.4 Billion Milestonebenzinga.com
This XRP price prediction explains what to expect now that the Ripple USD (RLUSD) stablecoin growth is accelerating this month.
Via Benzinga · September 5, 2026
Equity Bancshares Director Rogerson Buys 2,000 Shares for $100,000fool.com
The executive buys more shares as the stock price has climbed over 20% in 2026, signaling confidence in the company.
Via The Motley Fool · September 5, 2026
Sundar Pichai's Gemini App Grew From 400 Million to Over 1 Billion Monthly Users in a Little Over a Year. Does That Adoption Curve Justify Alphabet's AI Spending Binge?fool.com
No, but...
Via The Motley Fool · September 5, 2026
Why Deere Stock Hit an All-Time High This Weekfool.com
The recovery cycle for Deere's equipment could be just beginning.
Via The Motley Fool · September 5, 2026
Here's Why USA Rare Earth Is a Buy Before Its Next Earnings Reportfool.com
USA Rare Earth's revenue is about to jump.
Via The Motley Fool · September 5, 2026
There Are Only a Handful of S&P 500 Stocks That Yield Over 5%. Here's My Top Pick to Buy in September.fool.com
This is an excellent dividend stock at any time.
Via The Motley Fool · September 5, 2026
GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenuemarketbeat.com
GitLab posted 21.3% revenue growth and beat earnings estimates in Q2 FY2027, driven by its Flex consumption pricing model, and raised its full-year adjusted earnings guidance.
Via MarketBeat · September 5, 2026
Alphabet's Stock Slipped 2.2% After Sundar Pichai's Earnings Beat Was Inflated by a $77.1 Billion Unrealized Gain on Equity Holdings. Should Investors Discount That Gain When Judging the Real Growth Story?fool.com
Unrealized gains are lovely when they happen, but they can also turn into unrealized losses.
Via The Motley Fool · September 5, 2026